Law Articles
To search for a particular term please use the following search box.
Law Topics
Click on a Topic to see available articles for that topic.
- Accidents
- Administrative Law
- Admiralty Law
- Articles
- Banking
- Bankruptcy Law
- Canon Law
- Case Law
- Civil Law
- Civil Rights
- Class Action Lawsuits
- Commercial Law
- Common Law
- Comparative Law
- Constitutional Law
- Consumer Law
- Contracts
- Corporate Law
- Courts
- Criminal Law
- Cyber Law
- Dispute Resolution
- Employment Law
- Equity
- Evidence
- Family Law
- Fiduciary Law
- General Practice
- Government
- Health Law
- Immigration Law
- Insurance Law
- Intellectual Property
- International Law
- Jurisprudence
- Labor Law
- Law and Economics
- Maritime Law
- Military Law
- Natural Law
- Personal Injury Law
- Philosophy of Law
- Property Law
- Public Law
- Real Estate Law
- Social Security
- Space Law
- Statutory Law
- Tax Law
- Traffic Law
- Trusts and Estates
- Water Law
Return to Law Dictionary Index
Chicago Law Firm Files Bextra Class Action Lawsuit Against Pfizer
Source: Business Wire
Published: April 11, 2005
A class action lawsuit was filed against Pfizer Inc., on behalf of all persons who died or were injured by the pain relief drug, Bextra, the Chicago law firm Kenneth B. Moll & Associates, Ltd. announced Monday.
The Bextra lawsuit accuses pharmaceutical giant Pfizer of failing to properly research the known risks of Bextra, warn consumers of the fatal side effects, and withdraw the drug from the market even when the dangers became widely known.
Pfizer suspended sales of Bextra in the United States and the European Union on Thursday after the Food and Drug Administration concluded that its overall risk versus benefit profile is "unfavorable."
Bextra belongs to a class of drugs called Cox-2 inhibitors, including Celebrex, another Pfizer drug, and Vioxx, made by Merck & Company. All three painkillers have been amid controversy since September 2004, after Merck pulled Vioxx from the market because it was found to increase a patients' risk of heart attack and stroke after 18 months of use.
But unlike Vioxx, Bextra was taken off the market because of its potential to cause a rare but serious skin reaction, which is already disclosed on its label, Pfizer said.
The Bextra lawsuit, filed in the Federal District Court for the Northern District of Illinois, seeks compensation for those who have died and been injured as a result of their use of Bextra.
Read Full Story at Business Wire